Literature DB >> 8670136

Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.

D Brömme1, J L Klaus, K Okamoto, D Rasnick, J T Palmer.   

Abstract

Peptidyl vinyl sulphones are a novel class of extremely potent and specific cysteine protease inhibitors. They are highly active against the therapeutically important cathepsins O2, S and L. The highest kinact/K1 values exceed 10(7)M(-1) x s(-1) for cathepsin S and 10(5)M(-1) x s(-1) for cathepsins O2 and L. To study the primary specificity site of the novel human cathepsin O2 and the effectiveness of this novel class of inhibitors, a series of peptidyl vinyl sulphones with variations in the P2 residue was synthesized. Leucine in the P2 position was proven to be the most effective residue for cathepsin O2 and also for cathepsins S and L. Cathepsins O2 and S share a decreased accessibility towards P2 hydrophobic non-branched residues such as aminohexanoic acid (norleucine), methionine and oxidized methionine, but are distinguished by their different affinity towards phenylalanine in the P2 position. In contrast, cathepsin S accepts a broader range of hydrophobic residues in its S2 subsite than cathepsins O2 and L. The primary specificity-determining subsite pocket S2 in cathepsin O2 appears to be spatially more restricted than those of cathepsins S and L.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670136      PMCID: PMC1217200          DOI: 10.1042/bj3150085

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Novel N-peptidyl-O-acyl hydroxamates: selective inhibitors of cysteine proteinases.

Authors:  D Brömme; U Neumann; H Kirschke; H U Demuth
Journal:  Biochim Biophys Acta       Date:  1993-10-06

2.  Peptidyl diazomethanes as inhibitors of cysteine and serine proteinases.

Authors:  E Shaw
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

3.  Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme.

Authors:  D Brömme; P R Bonneau; P Lachance; B Wiederanders; H Kirschke; C Peters; D Y Thomas; A C Storer; T Vernet
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

4.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease.

Authors:  G P Shi; J S Munger; J P Meara; D H Rich; H A Chapman
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

5.  Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B.

Authors:  B J Gour-Salin; P Lachance; C Plouffe; A C Storer; R Ménard
Journal:  J Med Chem       Date:  1993-03-19       Impact factor: 7.446

6.  Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation.

Authors:  D J Buttle; C J Handley; M Z Ilic; J Saklatvala; M Murata; A J Barrett
Journal:  Arthritis Rheum       Date:  1993-12

7.  Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone.

Authors:  T Inaoka; G Bilbe; O Ishibashi; K Tezuka; M Kumegawa; T Kokubo
Journal:  Biochem Biophys Res Commun       Date:  1995-01-05       Impact factor: 3.575

8.  Hydrolysis of amyloid precursor protein-derived peptides by cysteine proteinases and extracts of rat brain clathrin-coated vesicles.

Authors:  N Marks; M J Berg; L M Chi; J Choi; R Durrie; J Swistok; R C Makofske; W Danho; V S Sapirstein
Journal:  Peptides       Date:  1994-01       Impact factor: 3.750

9.  Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Implication for treatment of rheumatoid arthritis.

Authors:  N K Ahmed; L A Martin; L M Watts; J Palmer; L Thornburg; J Prior; R E Esser
Journal:  Biochem Pharmacol       Date:  1992-09-25       Impact factor: 5.858

10.  The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones. Comparison with the inhibition of cathepsin L and calpain.

Authors:  E Shaw; S Mohanty; A Colic; V Stoka; V Turk
Journal:  FEBS Lett       Date:  1993-11-22       Impact factor: 4.124

View more
  29 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

2.  Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.

Authors:  V J Chan; P M Selzer; J H McKerrow; J A Sakanari
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.

Authors:  Adéla Jílková; Pavlína Rezácová; Martin Lepsík; Martin Horn; Jana Váchová; Jindrich Fanfrlík; Jirí Brynda; James H McKerrow; Conor R Caffrey; Michael Mares
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

4.  Antimalarial synergy of cysteine and aspartic protease inhibitors.

Authors:  A Semenov; J E Olson; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Crystal structure of human cathepsin S.

Authors:  M E McGrath; J T Palmer; D Brömme; J R Somoza
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

6.  Quantification of cathepsins B and L in cells.

Authors:  R Xing; A K Addington; R W Mason
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

7.  PACMANS: A bioinformatically informed algorithm to predict, design, and disrupt protease-on-protease hydrolysis.

Authors:  Meghan C Ferrall-Fairbanks; Zachary T Barry; Maurizio Affer; Marc A Shuler; Ellen W Moomaw; Manu O Platt
Journal:  Protein Sci       Date:  2017-03-01       Impact factor: 6.725

8.  Cysteine protease inhibitors as chemotherapy: lessons from a parasite target.

Authors:  P M Selzer; S Pingel; I Hsieh; B Ugele; V J Chan; J C Engel; M Bogyo; D G Russell; J A Sakanari; J H McKerrow
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

9.  Role of proteases in the pathophysiology of cardiac disease.

Authors:  Raja B Singh; Sucheta P Dandekar; Vijayan Elimban; Suresh K Gupta; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

10.  RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening.

Authors:  Saša Stefanić; Jan Dvořák; Martin Horn; Simon Braschi; Daniel Sojka; Debbie S Ruelas; Brian Suzuki; Kee-Chong Lim; Stephanie D Hopkins; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2010-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.